ConductScience.org, home

Paper2392685

Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant.

LaRosa GJ and 9 others. Science, 1990. Cited by 707 papers, by iCite.

Cite this record

ConductScience Library. Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. Papers, record 2392685. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2392685

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant.
PubMed
Journal
Science
PubMed
Year
1990
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
707
iCite
Relative citation ratio, by iCite
16.9
iCite
Revised in PubMed
2019-06-18
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1LaRosa GJG J
2Davide JPJ P
3Weinhold KK
4Waterbury JAJ A
5Profy ATA T
6Lewis JAJ A
7Langlois AJA J
8Dreesman GRG R
9Boswell RNR N
10Shadduck PP

Source PubMed

Download CSV of authors

Topics10

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HIV Envelope Protein gp120Major topic
HIV SeropositivityMajor topic
HIV-1Major topic
Amino Acid Sequence
Genetic Variation
Humans
Military Personnel
Molecular Sequence Data
Protein Conformation
United States

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Erratum in1990444Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant: corrections and clarifications.https://conductscience.org/library/papers/1990444

Source PubMed

Download CSV of comments and corrections

Cited by186

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 707 citations.

PMIDTitleJournalYearIn PapersSource
42021925Variations and evolution of HIV-1 provirus in peripheral blood under the pressure of ART.Virus Evol2026https://conductscience.org/library/papers/42021925PubMed
38263120The chemokine receptor CCR5: multi-faceted hook for HIV-1.Retrovirology2024https://conductscience.org/library/papers/38263120PubMed
35708645Novel small synthetic HIV-1 V3 crown variants: CCR5 targeting ligands.J Biochem2022https://conductscience.org/library/papers/35708645PubMed
34354709Employing Broadly Neutralizing Antibodies as a Human Immunodeficiency Virus Prophylactic & Therapeutic Application.Front Immunol2021https://conductscience.org/library/papers/34354709PubMed
34343443
V3-Loop genotypes do not predict maraviroc susceptibility of CCR5-tropic virus or clinical response through week 48 in HIV-1-infected, treatment-experienced persons receiving optimized background regimens.
Antivir Chem Chemother2021https://conductscience.org/library/papers/34343443PubMed
31087560Identification and CRISPR/Cas9 Inactivation of the C1s Protease Responsible for Proteolysis of Recombinant Proteins Produced in CHO Cells.Biotechnol Bioeng2019https://conductscience.org/library/papers/31087560PubMed
29731169Identification of Near-Pan-neutralizing Antibodies against HIV-1 by Deconvolution of Plasma Humoral Responses.Cell2018https://conductscience.org/library/papers/29731169PubMed
29343576Increased Epitope Complexity Correlated with Antibody Affinity Maturation and a Novel Binding Mode Revealed by Structures of Rabbit Antibodies against the Third Variable Loop (V3) of HIV-1 gp120.J Virol2018https://conductscience.org/library/papers/29343576PubMed
29237828Identification of Novel Structural Determinants in MW965 Env That Regulate the Neutralization Phenotype and Conformational Masking Potential of Primary HIV-1 Isolates.J Virol2018https://conductscience.org/library/papers/29237828PubMed
28539445Structure of Simian Immunodeficiency Virus Envelope Spikes Bound with CD4 and Monoclonal Antibody 36D5.J Virol2017https://conductscience.org/library/papers/28539445PubMed
27630234Rationally Designed Vaccines Targeting the V2 Region of HIV-1 gp120 Induce a Focused, Cross-Clade-Reactive, Biologically Functional Antibody Response.J Virol2016https://conductscience.org/library/papers/27630234PubMed
26109728Functional and Structural Characterization of Human V3-Specific Monoclonal Antibody 2424 with Neutralizing Activity against HIV-1 JRFL.J Virol2015https://conductscience.org/library/papers/26109728PubMed
25810537What Do Chaotrope-Based Avidity Assays for Antibodies to HIV-1 Envelope Glycoproteins Measure?J Virol2015https://conductscience.org/library/papers/25810537PubMed
25122783Visualization of retroviral envelope spikes in complex with the V3 loop antibody 447-52D on intact viruses by cryo-electron tomography.J Virol2014https://conductscience.org/library/papers/25122783PubMed
24862329Bioinformatic analysis of HIV-1 entry and pathogenesis.Curr HIV Res2014https://conductscience.org/library/papers/24862329PubMed
24314667
Specific sequences commonly found in the V3 domain of HIV-1 subtype C isolates affect the overall conformation of native Env and induce a neutralization-resistant phenotype independent of V1/V2 masking.
Virology2014https://conductscience.org/library/papers/24314667PubMed
24027570Mimicking Protein-Protein Interactions through Peptide-Peptide Interactions: HIV-1 gp120 and CXCR4.Front Immunol2013https://conductscience.org/library/papers/24027570PubMed
23864637Rabbit anti-HIV-1 monoclonal antibodies raised by immunization can mimic the antigen-binding modes of antibodies derived from HIV-1-infected humans.J Virol2013https://conductscience.org/library/papers/23864637PubMed
22076145Indirect detection of an epitope-specific response to HIV-1 gp120 immunization in human subjects.PLoS One2011https://conductscience.org/library/papers/22076145PubMed
21636577Interaction of the HIV-1 gp120 viral protein V3 loop with bacterial lipopolysaccharide: a pattern recognition inhibition.J Biol Chem2011https://conductscience.org/library/papers/21636577PubMed

See all 186 cited byDownload CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
ITIH43700PubTator's text mininghttps://conductscience.org/library/genes/3700

Source NCBI Gene

Download CSV of genes

Data10

The data bank entries PubMed's record names. Trial numbers are under Trials.

Data bankAccessionSource
GENBANKM37586GENBANK
GENBANKM61417GENBANK
GENBANKM61418GENBANK
GENBANKM61419GENBANK
GENBANKM61420GENBANK
GENBANKM61421GENBANK
GENBANKM61422GENBANK
GENBANKM61423GENBANK
GENBANKM61424GENBANK
GENBANKM61425GENBANK

Download CSV of data

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Drugs

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2392685

GET https://conductscience.org/api/papers/v1/2392685/cited_by?page=2